Case report: rare case of mechanical bowel obstruction due to strangulation by gastric stimulator electrodes

BMC Surgery

Christof Ihle¹  Stephan Axer¹  Hans Lederhuber¹ 

[1] Department of General Surgery, Torsby Hospital, Värmland County Council, Lasarättsvägen 8, Torsby, 68529, Sweden

关键词: Implantable stimulation electrodes;    Ileus;    Gastroparesis;   

Others  :  1149086
DOI  :  10.1186/s12893-015-0022-4

 received in 2014-10-15, accepted in 2015-03-18,  发布年份 2015

【 摘 要 】

Background

Implantation of a gastric stimulator is a feasible surgical therapy for patients with therapy refractory gastroparesis. In addition it seems to be a promising alternative for treating morbid obesity. We present for the first time the surgical emergency of small bowel obstruction due to strangulation by gastric stimulator electrodes.

Case presentation

A 59-year-old Caucasian female had undergone implantation of a gastric stimulator to cope with the symptoms of a partial gastroparesis. Eight years after the operation, the patient began to present repeatedly to different hospitals because of abdominal pain and nausea. Symptoms and imaging indicated ileus, which could always be treated conservatively. The underlying pathology could not ultimately be determined and the symptoms were eventually considered gastroparesis-related. After two years the patient was finally referred in circulatory shock due to peritonitis with underlying small bowel obstruction. Emergency laparotomy revealed small bowel strangulation by the gastric stimulator electrodes.

Conclusion

Repeated presentation of a patient with an unfamiliar treatment modality must raise suspicion of unusual complications. Specialist surgeons treating with innovative methods should provide proper information that is accessible to everyone who might have to treat possible complications.

【 授权许可】

   
2015 Lederhuber et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Lin Z, Forster J, Sarosiek I, McCallum RW: Treatment of gastroparesis with electrical stimulation. Dig Dis Sci 2003, 48:837-48.
• [2]Voeller GR: Gastric electrical stimulation: a novel treatment for gastroparesis. JSLS 2006, 10:131.
• [3]Abell TL: Gastric electric stimulation is a viable option in gastroparesis treatment. Nat Clin Pract Gastroenterol Hepatol 2009, 6:E8-13.
• [4]Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-8.
• [5]Abell TL, Van Cutsem E, Abrahamsson H, Huizinga JD, Konturek JW, Galmiche JP, et al.: Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002, 66:204-12.
• [6]de Csepel J, Shapsis A, Jordan C: Gastric electrical stimulation: a novel treatment for gastroparesis. JSLS 2005, 9:364-7.
• [7]Mizrahi M, Ben Ya'acov A, Ilan Y: Gastric stimulation for weight loss. World J Gastroenterol 2012, 18:2309-19.
• [8]Shikora SA: Implantable gastric stimulation for weight loss. J Gastrointest Surg 2004, 8:408-12.
• [9]Champion JK, Williams M, Champion S, Gianos J, Carrasquilla C: Implantable gastric stimulation to achieve weight loss in patients with a low body mass index: early clinical trial results. Surg Endosc 2006, 20:444-7.
• [10]Cha R, Marescaux J, Diana M: Updates on gastric electrical stimulation to treat obesity: Systematic review and future perspectives. World J Gastrointest Endosc 2014, 6:419-31.
• [11]Kang YW, Kim CH: Gastroparesis: diagnostic and therapeutic strategies. Dig Dis 1992, 10:181-9.
• [12]Hornbuckle K, Barnett JL: The diagnosis and work-up of the patient with gastroparesis. J Clin Gastroenterol 2000, 30:117-24.
• [13]Intagliata N, Koch KL: Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment. Curr Gastroenterol Rep 2007, 9:270-9.
• [14]Shafi MA, Pasricha PJ: Post-surgical and obstructive gastroparesis. Curr Gastroenterol Rep 2007, 9:280-5.
• [15]McCallum RW, Sarosiek I, Parkman HP, Snape W, Brody F, Wo J, et al.: Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil 2013, 25:815-e636.
• [16]Hasler WL: Gastroparesis–current concepts and considerations. Medscape J Med 2008, 10:16.
• [17]Gentilcore D, O'Donovan D, Jones KL: Nutrition therapy for diabetic gastroparesis. Current Diabetes Rep 2003, 3:418-26.
• [18]Camilleri M, Parkman HP, Shafi MA, Abell TL: Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013, 108:18-37.
• [19]Li J-L, Li M, Pang B, Zhou Q, Tian J-X, Liu H-X, et al.: Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis. World J Gastroenterol 2014, 20:8674-80.
• [20]Akindipe OA, Faul JL, Vierra MA, Triadafilopoulos G, Theodore J: The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest 2000, 117:907-10.
• [21]Eckhauser FE, Knol JA, Raper SA, Guice KS: Completion gastrectomy for postsurgical gastroparesis syndrome. Preliminary results with 15 patients. Ann Surg 1988, 208:345-53.
• [22]Eckhauser FE, Conrad M, Knol JA, Mulholland MW, Colletti LM: Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg 1998, 64:711-6. discussion 716–7
• [23]Bell DS, Ovalle F: Gastroparesis cured by gastrectomy. Diabetes Care 1999, 22:1000-1.
• [24]Jones MP, Maganti K: A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003, 98:2122-9.
• [25]Borrazzo EC: Surgical management of gastroparesis: gastrostomy/jejunostomy tubes, gastrectomy, pyloroplasty, gastric electrical stimulation. J Gastrointest Surg 2013, 17:1559-61.
• [26]Dee A, Kearns K, O'Neill C, Sharp L, Staines A, O'Dwyer V, et al.: The direct and indirect costs of both overweight and obesity: a systematic review. BMC Res Notes 2014, 7:242. BioMed Central Full Text
• [27]Karnehed N. Socioeconomic Consequences of Obesity. 2008. https://publications.ki.se/xmlui/bitstream/handle/10616/39602/thesis.pdf?sequence=1. Accessed 19 Feb 2015.
• [28]Frederick CB, Snellman K, Putnam RD: Increasing socioeconomic disparities in adolescent obesity. Proc Natl Acad Sci U S A 2014, 111:1338-42.
• [29]Bray GA, Ryan DH: Update on obesity pharmacotherapy. Ann N Y Acad Sci 2014, 1311:1-13.
• [30]Baretić M: Obesity drug therapy. Minerva Endocrinol 2013, 38:245-54.
• [31]Maggard MA: Meta-Analysis: Surgical Treatment of Obesity. Ann Intern Med 2005, 142:547-59.
• [32]Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, et al.: Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 2013, 310:2416-25.
• [33]Iannelli A, Facchiano E, Gugenheim J: Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2006, 16:1265-71.
• [34]Paroz A, Calmes JM, Giusti V, Suter M: Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a continuous challenge in bariatric surgery. Obes Surg 2006, 16:1482-7.
• [35]Busetto L, Mazza M, Salvalaio S, De Stefano F, Marangon M, Calò E, et al.: Obesity treatment in elderly outpatients: predictors of efficacy and drop-out. Eat Weight Disord 2009, 14:e56-65.